Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer

Loading...
Thumbnail Image

Date

Authors

Griniatsos, J.
Diamantis, E.
Gioti, J.
Karyda, I.
Vassilopoulos, P. P.
Agnanti, N.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Anticancer Res

Book name

Book series

Book edition

Alternative title / Subtitle

Description

Recently, using an ultrasensitive time-resolved immuno-fluorometric assay, PSA immunoreactivity (IR-PSA) was found in breast tumor cytosols. We retrospectively studied 219 breast cancer patients, measuring IR-PSA in the tumor cytosols, and classified the breast cancers as either PSA positive or PSA negative based on an IR-PSA cut off level of 1 pg/mg. Multivariated analysis showed that IR-PSA is an independent favourable prognostic indicator for postmenopausal, node positive breast cancer patients. Additionally, IR-PSA correlates with reduced risk of relapse in ER+ve tumors and is negatively correlated with mutated p53, which increases the risk of relapse.

Description

Keywords

Adult, Aged, Breast Neoplasms/*metabolism/pathology, Female, Fluorometry, Humans, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Prostate-Specific Antigen/*metabolism, Retrospective Studies, Tumor Suppressor Protein p53/metabolism

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/9584052

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By